A Value Proposition in Lean Biotech Times
In a prolonged biotech industry and real estate slump, one lab space provider is bucking the trend and expanding its Greater Boston portfolio: LabShares, under CEO Philip Borden.
Signs of Life in Boston Biotech CRE
Little tiny green shoots are poking up here and there, with leasing activity running well ahead of 2024 totals and the pace of vacancy growth slowing down.
Funding Climate Clouds Biotech Growth Trajectory
The Boston metro has been a leader in life science research for decades, and while its upward trajectory continued so far this year, a few headwinds are mounting.
Jumbo Capital Buys Bedford Lab Property for $72.5M
A 143,616-square-foot Bedford lab building that includes the headquarters of Homology Medicines Inc. has been acquired by Quincy-based Jumbo Capital Management and Iron Point Partners for $72.5 million.
Alexandria Buys Waltham Campus for $330M
A Waltham office campus that has potential to add more life science space following the pending departure of a major office tenant in 2021 has been sold to Alexandria Real Estate Equities for $330 million.
Newton Incubator Picks Recipient of Free Lab Space
A Cambridge startup will receive a year of free office-lab space at a Newton incubator that’s tapping into the life science growth in the western suburbs.
Report: Boston Lab Rents Rise 8 Percent
Demand for lab space remained strong in the second quarter, with asking rents in downtown Boston rising 8 percent in the second quarter.
Life Science Dominates Suburban Leasing Activity
Pursuing lab users continues to be an effective strategy for suburban Boston developers in early 2020, as life science tenants comprised a majority of space commitments in the first quarter.
